Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb)

Lentzsch, S., Lipe, B., Tuchman, S. A., Bahlis, N. J., Bensinger, W. I., Sebag, M., Sutherland, H. J., Monge, J., Gasparetto, C. J., Baljevic, M., Callander, N. S., Venner, C. P., White, D. J., Kotb, R., Chen, C. I., Schiller, G. J., Madan, S., Leblanc, R., DeCastro, A., … Biran, N. (2021). Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb). Blood, 138(Supplement 1), 1651–1651. https://doi.org/10.1182/blood-2021-150232
Authors:
Suzanne Lentzsch
Brea Lipe
Sascha A. Tuchman
Nizar J. Bahlis
William Bensinger
Michaël Sébag
Heather J. Sutherland
Jorge Monge
Cristina Gasparetto
Muhamed Baljević
Natalie S. Callander
Christopher P. Venner
Darrell White
Rami Kotb
Christine I. Chen
Gary J. Schiller
Sumit Madan
Richard LeBlanc
Andrew DeCastro
Ohad S. Bentur
Jatin J. Shah
Dane R. Van Domelen
Michael Kauffman
Sharon Shacham
Noa Biran
Affiliated Authors:
Suzanne Lentzsch
Subjects:
Publication Type:
Article
Unique ID:
10.1182/blood-2021-150232
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: